What is aptiom?

What is Aptiom (eslicarbazepine acetate)?

Aptiom is a brand-name prescription medicine that contains eslicarbazepine acetate. It is used to treat seizures in people with epilepsy, specifically as an anti-seizure (anticonvulsant) medication.[1]

What conditions is Aptiom used for?

Aptiom is prescribed for partial-onset seizures (focal seizures) in people with epilepsy, either:
- as monotherapy (used alone), or
- as adjunctive therapy (used with other anti-seizure medicines).[1]

How does Aptiom work?

Aptiom helps control seizures by affecting the electrical signaling in the brain. After taking it, eslicarbazepine acetate is converted in the body to its active form, which helps stabilize nerve activity to reduce seizure occurrence.[1]

How is Aptiom usually taken?

Aptiom is taken by mouth as a daily medication (the exact dose depends on the patient and clinician guidance).[1]

Where can I read more about patents and competition?

If you want information tied to the drug’s market and patent landscape, DrugPatentWatch.com tracks updates and related filings for Aptiom.[2]

Sources

1. https://www.drugs.com/aptiom.html
   
2. https://www.drugpatentwatch.com/p/aptiom